Compare · AIT vs CLGN
AIT vs CLGN
Side-by-side comparison of Applied Industrial Technologies Inc. (AIT) and CollPlant Biotechnologies Ltd (CLGN): market cap, price performance, sector, and recent activity on the wire.
Summary
- AIT operates in Consumer Discretionary, while CLGN operates in Health Care - the two are in different parts of the market.
- AIT is the larger of the two at $12.32B, about 2246.4x CLGN ($5.5M).
- AIT has been more active in the news (21 items in the past 4 weeks vs 2 for CLGN).
- AIT has more recent analyst coverage (12 ratings vs 1 for CLGN).
- Company
- Applied Industrial Technologies Inc.
- CollPlant Biotechnologies Ltd
- Price
- -
- -
- Market cap
- $12.32B
- $5.5M
- 1M return
- -
- -4.37%
- 1Y return
- -
- -87.71%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 21
- 2
- Recent ratings
- 12
- 1
Applied Industrial Technologies Inc.
Applied Industrial Technologies, Inc. distributes industrial products in North America, Australia, New Zealand, and Singapore. The company offers its products for maintenance, repair, and operational, as well as original equipment manufacturing customers. It operates in two segments, Service Center Based Distribution, and Fluid Power & Flow Control. The company distributes bearings, power transmission products, engineered fluid power components and systems, specialty flow control solutions, machinery and robotics automation products, industrial rubber products, linear motion components, tools, safety products, oilfield supplies, and other industrial and maintenance supplies; and offers motors, belting, drives, couplings, pumps, hydraulic and pneumatic components, filtration supplies, valves, fittings, process instrumentation, actuators, and hoses, as well as other related supplies for general operational needs of customers' machinery and equipment. It also operates fabricated rubber shops and service field crews that install, modify, and repair conveyor belts and rubber linings, as well as offer hose assemblies. In addition, the company offers equipment repair and technical support services. It offers industrial products through a network of service centers. The company serves various industries, including agriculture and food processing, cement, chemicals and petrochemicals, fabricated metals, forest products, industrial machinery and equipment, mining, oil and gas, primary metals, transportation, and utilities, as well as to government entities. Applied Industrial Technologies, Inc. was founded in 1923 and is headquartered in Cleveland, Ohio.
CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler for treating wrinkles; 3D Bioprinted breast implants that are used for the regeneration of breast tissue; injectable implants to promote breast tissue regeneration; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds. It has a co-development agreement with 3D Systems Corporation for a 3D bioprinted regenerative soft tissue matrix for use in breast reconstruction procedures in combination with an implant. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. CollPlant Biotechnologies Ltd. was founded in 2004 and is headquartered in Rehovot, Israel.
Latest AIT
- Vice President-CFO & Treasurer Wells David K. sold $643,439 worth of shares (1,812 units at $355.10), decreasing direct ownership by 5% to 32,050 units (SEC Form 4)
- VP-Sales & Marketing-USSC Vasquez Jason W exercised 7,700 shares at a strike of $53.87 and covered exercise/tax liability with 2,774 shares, increasing direct ownership by 32% to 20,259 units (SEC Form 4) to satisfy withholding obligation
- Applied Industrial Technologies Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- Director Tomczik Pamela J was granted 234 shares (SEC Form 4)
- SEC Form 3 filed by new insider Tomczik Pamela J
- Chief Accounting Officer Wagner Richard M was granted 215 shares, increasing direct ownership by 22% to 1,203 units (SEC Form 4)
- VP, General Mgr-Fluid Power Hoffner Warren E Iii was granted 1,551 shares and covered exercise/tax liability with 320 shares, increasing direct ownership by 3% to 41,775 units (SEC Form 4) (withholding tax)
- VP-Chief HR Officer Loring Kurt W. was granted 1,752 shares and covered exercise/tax liability with 628 shares, increasing direct ownership by 6% to 19,992 units (SEC Form 4) to satisfy withholding tax
- President and CEO Schrimsher Neil A covered exercise/tax liability with 4,876 shares and was granted 13,402 shares, increasing direct ownership by 7% to 136,893 units (SEC Form 4) (for tax liability)
- SEC Form 10-K filed by Applied Industrial Technologies Inc.
Latest CLGN
- SEC Form 6-K filed by CollPlant Biotechnologies Ltd
- SEC Form 6-K filed by CollPlant Biotechnologies Ltd
- SEC Form 6-K filed by CollPlant Biotechnologies Ltd
- SEC Form 6-K filed by CollPlant Biotechnologies Ltd
- SEC Form D filed by CollPlant Biotechnologies Ltd
- SEC Form 424B3 filed by CollPlant Biotechnologies Ltd
- SEC Form EFFECT filed by CollPlant Biotechnologies Ltd
- SEC Form F-3 filed by CollPlant Biotechnologies Ltd
- SEC Form 6-K filed by CollPlant Biotechnologies Ltd
- SEC Form 6-K filed by CollPlant Biotechnologies Ltd